Bot myths and fallacies leave two-thirds of businesses at higher risk of malicious attacks
New report from Netacea uncovers the bot myths believed by businesses —leaving them vulnerable Manchester,…
Month: March 2022
Bitrue to List Gaming Rewards Token $RUBY on 15/03
Christchurch, New Zealand–(Newsfile Corp. – March 15, 2022) – The $RUBY token will officially list…
Volt Information Sciences, Inc. Reports First Quarter 2022 Financial Results
Reports Year-Over-Year Revenue Growth and Improved Operating Results ORANGE, Calif.–(BUSINESS WIRE)–Volt Information Sciences, Inc. (“Volt”…
Quanergy Participates at ISC West to Showcase 3D LiDAR Solutions for Advanced Security and Business Intelligence
Quanergy solutions to be displayed at booth 32091 and by Genetec (booth 13062), Teledyne FLIR…
Radiant Logic Appoints Board of Directors with Accomplished Industry Veterans
Kris Lovejoy, Matt Medeiros, and Praerit Garg join Identity Data Fabric leader to revolutionize the…
Woebot Health Secures $9.5 Million Investment From Leaps by Bayer
Strategic funding marks Leaps by Bayer’s first in mental health and aims to help improve…
Mannatech Reports Fourth Quarter 2021 Financial Results
FLOWER MOUND, Texas–(BUSINESS WIRE)–Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to…
Affinity Brings Relationship Intelligence to Europe
Opening operations based in London, Affinity expands operations to bring relationship intelligence to more dealmakers…
iGrafx Appoints Process Automation Leader John D. Barone as Executive Vice President of Global Sales to Accelerate Revenue and Strategic Partnerships
TUALATIN, Ore. & PORTLAND, Ore.–(BUSINESS WIRE)–#automation—iGrafx, a worldwide leader in digital business transformation and process…
SentinelOne to Acquire Attivo Networks, Bringing Identity to XDR
SentinelOne Adds Leading Identity Threat Detection and Response (ITDR) Technology for Enterprise Zero Trust Adoption…
Aizon and aggity Launch Partnership to Help Biopharmaceutical Firms Increase the Speed and Efficiency of Drug Manufacturing
Through Combined Efforts, the Partnership Will Advance Pharma 4.0 Transformation in Southern Europe SAN FRANCISCO–(BUSINESS…
Logicalis appoints Damian Skendrovic as EMEA CEO
London, 15th March 2022: Logicalis, an international IT solutions and managed service provider, is pleased…
Santhera and ReveraGen to Present Efficacy and Safety Data with Vamorolone at 2022 Muscular Dystrophy Association Conference
Pratteln, Switzerland, and Rockville, MD, USA, March 15, 2022 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen…
Santhera Completes Ordinary Capital Increase to Create Treasury Shares for Future Financing
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN…
Sanofi announces €300 million collaboration with Blackstone Life Sciences to advance an innovative treatment for multiple myeloma
Sanofi announces €300 million collaboration with Blackstone Life Sciences to advance an innovative treatment for…
iBASIS Partners With Mavenir to Launch CPaaS and Introduce Global Programmable Communications to Service Providers
Enables Service Providers to capitalize on $21.7B* CPaaS market opportunity Carrier-grade and enterprise-centric CPaaS ready…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of CIRCOR International, Inc. (CIR) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Imugene Announces Clinical Trial Collaboration with Merck & Co., Inc., Kenilworth, NJ., USA to Evaluate HER-Vaxx in Combination with Pembrolizumab for Treatment of Gastric Cancer
New clinical trial supply agreement with MSD, a tradename of Merck & Co., Inc., Kenilworth,…
Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments
Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global…
Agile Therapeutics Announces Closing of $4.85 Million Registered Direct Offering
PRINCETON, N.J., March 14, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile Therapeutics”…